113 related articles for article (PubMed ID: 27655291)
1. Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH.
Pitoia F; Abelleira E; Cross G
Endocrine; 2017 Jan; 55(1):200-208. PubMed ID: 27655291
[TBL] [Abstract][Full Text] [Related]
2. Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial.
Schlumberger M; Leboulleux S; Catargi B; Deandreis D; Zerdoud S; Bardet S; Rusu D; Godbert Y; Buffet C; Schvartz C; Vera P; Morel O; Benisvy D; Bournaud C; Toubert ME; Kelly A; Benhamou E; Borget I
Lancet Diabetes Endocrinol; 2018 Aug; 6(8):618-626. PubMed ID: 29807824
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
[TBL] [Abstract][Full Text] [Related]
4. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study.
De Marchi AF; de Macedo ABT; Soares CSP; Bolfi F; Iessi MRG; de Oliveira CC; Koga KH; Moriguchi SM; Tagliarini JV; da Silva Mazeto GMF
Arch Endocrinol Metab; 2021 Nov; 65(4):428-435. PubMed ID: 34283903
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer.
Choi S; Na CJ; Kim J; Han YH; Kim HK; Jeong HJ; Sohn MH; Lim ST
Nucl Med Mol Imaging; 2015 Jun; 49(2):115-21. PubMed ID: 26085856
[TBL] [Abstract][Full Text] [Related]
7. TSH ≥30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
Ju N; Hou L; Song H; Qiu Z; Wang Y; Sun Z; Luo Q; Shen C
Eur Thyroid J; 2023 Aug; 12(4):. PubMed ID: 37022724
[TBL] [Abstract][Full Text] [Related]
8. Predicting clinical outcomes of patients with serum thyroglobulin antibodies after thyroidectomy for differentiated thyroid cancer: a retrospective study from a UK regional center.
Anderson H; Lim KH; Gull S; Oprean R; Spence K; Cvasciuc T
Minerva Endocrinol (Torino); 2024 Mar; 49(1):60-68. PubMed ID: 37428110
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer.
Nesari Javan F; Askari E; Shafiei S; Roshanravan V; Aghaei A; Ayati N; Zakavi SR
Endocr Pract; 2024 Mar; 30(3):209-217. PubMed ID: 38092290
[TBL] [Abstract][Full Text] [Related]
10. Impact factors of benefiting from initial 131 I ablation in patients with intermediate-risk differentiated thyroid carcinoma: a study based on a re-evaluation of therapeutic response.
Ren L; Hu Y; Hu Y; Xiao D; Sun J; Zhu B; Zhang C
Nucl Med Commun; 2024 Mar; 45(3):188-195. PubMed ID: 38165164
[TBL] [Abstract][Full Text] [Related]
11. Preparation with recombinant humanized thyroid-stimulating hormone before radioiodine ablation after thyroidectomy: a systematic review.
Yoo J; Cosby R; Driedger A
Curr Oncol; 2009 Sep; 16(5):23-31. PubMed ID: 19862359
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Effectiveness of Triiodothyronine Suppression and Withdrawal Versus Thyrogen Injections in Thyroid Cancer Assessments.
Abdulhameed NM; Janabi MA
Cureus; 2023 Dec; 15(12):e51061. PubMed ID: 38269223
[TBL] [Abstract][Full Text] [Related]
13. A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate‑ and high‑risk differentiated thyroid cancer patients: a bi-center retrospective study.
Wen R; Zhao M; Chen C; Yang Y; Zhang B
Endocrine; 2023 Dec; ():. PubMed ID: 38085420
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
Wang C; Lu G; Li Y; Liu X; Wang G; Lu C; Li J; Luo Q; Zhang Q; Sun M; Wang X; Wang R
Front Endocrinol (Lausanne); 2023; 14():1217092. PubMed ID: 37600705
[TBL] [Abstract][Full Text] [Related]
15. BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma.
Repaci A; Vicennati V; Paccapelo A; Cavicchi O; Salituro N; Monari F; de Biase D; Tallini G; Altimari A; Gruppioni E; Fiorentino M; Pagotto U
Int J Endocrinol; 2019; 2019():3081497. PubMed ID: 31093278
[TBL] [Abstract][Full Text] [Related]
16. Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
Wu J; Hu X; Seal P; Amin P; Diederichs B; Paschke R
Eur Thyroid J; 2023 Aug; 12(5):. PubMed ID: 37439446
[TBL] [Abstract][Full Text] [Related]
17. Does it work in childhood and adolescence? The predictive role of postoperative/preablative stimulated thyroglobulin levels in paediatric thyroid cancer. A systematic review of the literature.
Piccardo A; Fiz F; Bottoni G; Foppiani L; Albano D; Bertagna F; Catrambone U; Mariani F; Sambucco B; Massollo M; Treglia G; Trimboli P
Rev Endocr Metab Disord; 2024 Feb; 25(1):53-63. PubMed ID: 37743443
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Prognostic Value Between Stimulated and Nonstimulated Thyroglobulins in Differentiated Thyroid Cancer: A Retrospective Study.
Son J; Hong CM; Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC
Nucl Med Mol Imaging; 2023 Dec; 57(6):257-264. PubMed ID: 37982102
[TBL] [Abstract][Full Text] [Related]
19. Clinical Efficacy of Levothyroxine Sodium plus I 131 in the Treatment of Patients with Thyroidectomy and Its Effect on the Levels of Thyroglobulin and Thyrotropin.
Pang YL; Wang YP; Cheng K
Evid Based Complement Alternat Med; 2022; 2022():9557061. PubMed ID: 35958920
[TBL] [Abstract][Full Text] [Related]
20. Monitoring Thyroglobulin Following Total Thyroidectomy After Lobectomy.
Chow TL
JAMA Otolaryngol Head Neck Surg; 2024 Apr; 150(4):357. PubMed ID: 38421664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
